Strata Critical Medical Inc (SRTA) Price Prediction & ForecastSRTAStrata Critical Medical Inc

Alphio's SRTA stock price prediction model matches the current Strata Critical Medical Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $4.75 (+1.95%). The 1-week path is $4.86 (+4.26%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Strata Critical Medical Inc (SRTA) is a good buy right now due to its recent strong earnings report showing a 15.1% sequential increase in clinical revenue for Q2 2026, reaching $24.3 million, and an upgraded EBITDA guidance of $33 million to $35 million for the year. The current price of $4.66 is attractive given the potential for significant upside, especially considering the projected trajectory based on similar historical patterns, which indicates a potential increase of 424.67%. However, investors should be cautious of the negative net income trend, with a reported loss of $10.5 million in Q2 2026, which poses a risk to profitability.

Strata Critical Medical Inc (SRTA) last closed at $4.66, losing -1.06%. These facts feed the 1-day and 1-week SRTA price prediction above.